We compared the performance of SARS-CoV-2 neutralising antibody testing between 12
European laboratories involved in convalescent plasma trials. Raw titres differed almost 100 …

Background Serological assays are being used to monitor antibody responses in individuals
who had SARS-CoV-2 infection and those who received a COVID-19 vaccine. We aimed to …

High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-
2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the …

Abstract Background and Objectives There is a need for conversion of SARS‐CoV‐2
serology data from different laboratories to a harmonized international unit. We aimed to …

Background Serological surveys have been the gold standard to estimate numbers of SARS-
CoV-2 infections, the dynamics of the epidemic, and disease severity. Serological assays …

Longitudinal analysis of clinical serology assay performance and neutralising antibody
levels in COVID19 convalescents - PMC Back to Top Skip to main content NIH NLM Logo …

We analysed factors associated with neutralising antibody levels in 330 convalescent
plasma donors. Women and younger donors were more likely not to have measurable …

We reviewed the diagnostic accuracy of SARS-CoV-2 serological tests. Random-effects
models yielded a summary sensitivity of 82% for IgM, and 85% for IgG and total antibodies …

Serological reactivity was analysed in plasma from 436 individuals with a history of disease
compatible with COVID-19, including 256 who had been laboratory-confirmed with SARS …

Background To control epidemic waves, it is important to know the susceptibility to SARS-
CoV-2 and its evolution over time in relation to the control measures taken. Aim To assess …